eli lilly glp 1 agonist Drugmaker announced that the FDA approved its daily GLP-1 pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports. https://abcnewslive.visitlink.me/pYGbNh What's Coming Next for GLP-1
Description
Circulation 1983;67(6):13406
N Engl J Med (2022) 387:20516
2020;8(19):e14607
Conclusions and Relevance: Patent and regulatory reform is needed to ensure timely generic entry of GLP-1 receptor agonists
